pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·1h ago·2 min read
save

U.S. bioscience jobs up 7% from 2021 to 2025: Report

Bioscience employment rose in 41 states, though not in California, according to a new report from the Biotechnology Innovation Organization and the Council of State Bioscience Associations.

Nov 2, 2026·read at BioSpace ↗RegulatoryNeutral

News Job Trends U.S. bioscience jobs up 7% from 2021 to 2025: Report November 2, 2026 | 2 min read | Angela Gabriel Twitter LinkedIn Facebook Email Print Bioscience employment rose in 41 states, though not in California, according to a new report from the Biotechnology Innovation Organization and the Council of State Bioscience Associations. The U.S.

bioscience industry experienced employment and business establishment growth from 2021 to 2025, according to a new report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA). The industry directly employed 2.31 million people across more than 156,000 businesses last year, representing 7% and 22% jumps, respectively, from 2021.Employment increased in 41 states, plus the District of Columbia and Puerto Rico. Absolute job growth leaders were Texas, Florida, Massachusetts, Illinois, North Carolina, Pennsylvania, New York, Ohio and New Jersey.Data were mixed when comparing Massachusetts and the nation’s largest bioscience employer, California.

In Massachusetts, employment rose 10% from 2021 to 2025, reaching 145,864 industry jobs across 5,934 business establishments last year. However, California had a 1.5% employment decline, with 334,448 jobs across 15,719 businesses in 2025. Among the highlights for Massachusetts:Research, testing and medical laboratories, the state’s largest bioscience subsector, grew by 14.6% from 2021 to 2025, surpassing the 8.1% increase for the nation.Pharmaceuticals employment increased 9.7% from 2021 to 2025, outpacing the 5.4% change in the U.S.Annual bioscience wages averaged $219,393 last year, 115% higher than Massachusetts’ private-sector average of $101,877.Despite California’s employment decline, there was positive news for the state.Research, testing and medical laboratories, the state’s largest bioscience subsector, grew 2.5%.California’s overall bioscience employment concentration was 25% higher than the national average.Annual bioscience wages averaged $185,005 last year, 90% higher than the state’s private-sector average of $97,184.Research, testing and medical labs was not only California and Massachusetts’ largest bioscience subsector but the nation’s as well.

It employed more than 779,000 people in the U.S. in 2025, which represented about one-third of the country’s bioscience employment. From 2021 to 2025, the subsector’s jobs grew 8.1% and its establishments 37%.While highlighting the report’s positive data, BIO President and CEO John Crowley said in a press release that the U.S.

must continue promoting an environment that supports scientific discovery and strengthens the country’s leadership in biotechnology. “This report makes clear that we cannot take that strength for granted,” he said. “Now is the time to invest in America’s biotech ecosystem, advance policies that foster innovation and lay the groundwork for America’s long-term leadership for years to come.

The public policies enacted today at the national and state level will directly impact whether American biotech continues to thrive here at home and where the next generation of breakthroughs will be developed.” Subscribe to Career Insider! Job market trends, layoffs and career advice to manage your life sciences career Twitter LinkedIn Facebook Email Print Labor market California Massachusetts United States Puerto Rico Texas Florida Illinois North Carolina Pennsylvania New York Ohio New Jersey Biotechnology Innovation Organization (BIO) Angela Gabriel Angela Gabriel is content manager, life sciences careers, at BioSpace. She covers the biopharma job market, job trends and career advice, and produces client content.

You can reach her at angela.gabriel@biospace.com and follow her on LinkedIn.

source

Reporting by BioSpace.

read at BioSpace ↗
532 words · retrieved 33m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 47m agoTiziana touts multiple sclerosis win at lower dose as high dose misses markBioSpace
  • 55m agoVistagen cuts workforce for second time in 2026BioSpace
  • 59m agoCell therapy investment grows as safety events rankle Big Pharma's CAR T autoimmune pushBioSpace
  • 1h agoUniQure snags May Day decision date for Huntington’s gene therapy after arduous yearBioSpace
  • 3h agoSignificant stock movers of October: Biohaven climbs, ArriVent divesBioSpace